- NZ$2.37bn
- NZ$4.05bn
- NZ$760.70m
- 51
- 85
- 17
- 51
Annual balance sheet for Ryman Healthcare, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 20.2 | 28.3 | 27.9 | 41.8 | 17.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 543 | 671 | 719 | 155 | 140 |
Total Inventory | |||||
Prepaid Expenses | |||||
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,659 | 2,091 | 2,205 | 1,135 | 1,020 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 9,172 | 10,966 | 12,511 | 11,904 | 12,063 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 6,342 | 7,532 | 7,847 | 8,157 | 7,802 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,829 | 3,435 | 4,664 | 3,746 | 4,261 |
Total Liabilities & Shareholders' Equity | 9,172 | 10,966 | 12,511 | 11,904 | 12,063 |
Total Common Shares Outstanding |